<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="EN"><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title>PLoS ONE</journal-title><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">08-PONE-RA-04953R1</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0003291</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline"><subject>Cell Biology/Cell Adhesion</subject><subject>Cell Biology/Leukocyte Signaling and Gene Expression</subject><subject>Immunology/Immune Response</subject><subject>Immunology/Leukocyte Activation</subject></subj-group></article-categories><title-group><article-title>Signal Regulatory Protein &#x003b1; Negatively Regulates &#x003b2;<sub>2</sub> Integrin-Mediated Monocyte Adhesion, Transendothelial Migration and Phagocytosis</article-title><alt-title alt-title-type="running-head">SIRP&#x003b1; Regulates THP-1 Function</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Dan-Qing</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Li-Min</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Guo</surname><given-names>Ya-Lan</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Bai</surname><given-names>Rui</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Chen</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Bian</surname><given-names>Zhen</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Chen-Yu</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Zen</surname><given-names>Ke</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="corresp" rid="cor1"><sup>&#x0002a;</sup></xref></contrib></contrib-group><aff id="aff1"><label>1</label><addr-line>Jiangsu Diabetes Research Center, State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, Jiangsu, China</addr-line></aff><aff id="aff2"><label>2</label><addr-line>Jiangsu CDC-Nanjing University Joint Institute for Virology, Nanjing, Jiangsu, China</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Hartl</surname><given-names>Dominik</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">Yale University School of Medicine, United States of America</aff><author-notes><corresp id="cor1">&#x0002a; E-mail: <email>kzen@nju.edu.cn</email></corresp><fn fn-type="con"><p>Conceived and designed the experiments: CYZ KZ. Performed the experiments: DQL LML YLG RB CW ZB KZ. Analyzed the data: DQL LML YLG RB KZ. Contributed reagents/materials/analysis tools: CYZ. Wrote the paper: KZ.</p></fn></author-notes><pub-date pub-type="collection"><year>2008</year></pub-date><pub-date pub-type="epub"><day>29</day><month>9</month><year>2008</year></pub-date><volume>3</volume><issue>9</issue><elocation-id>e3291</elocation-id><history><date date-type="received"><day>3</day><month>6</month><year>2008</year></date><date date-type="accepted"><day>7</day><month>9</month><year>2008</year></date></history><copyright-statement>Liu et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</copyright-statement><copyright-year>2008</copyright-year><abstract><sec><title>Background</title><p>Signal regulate protein &#x003b1; (SIRP&#x003b1;) is involved in many functional aspects of monocytes. Here we investigate the role of SIRP&#x003b1; in regulating &#x003b2;<sub>2</sub> integrin-mediated monocyte adhesion, transendothelial migration (TEM) and phagocytosis.</p></sec><sec><title>Methodology/Principal Findings</title><p>THP-1 monocytes/macropahges treated with advanced glycation end products (AGEs) resulted in a decrease of SIRP&#x003b1; expression but an increase of &#x003b2;<sub>2</sub> integrin cell surface expression and &#x003b2;<sub>2</sub> integrin-mediated adhesion to tumor necrosis factor-&#x003b1; (TNF&#x003b1;)&#x02013;stimulated human microvascular endothelial cell (HMEC-1) monolayers. In contrast, SIRP&#x003b1; overexpression in THP-1 cells showed a significant less monocyte chemotactic protein-1 (MCP-1)&#x02013;triggered cell surface expression of &#x003b2;<sub>2</sub> integrins, in particular CD11b/CD18. SIRP&#x003b1; overexpression reduced &#x003b2;<sub>2</sub> integrin-mediated firm adhesion of THP-1 cells to either TNF&#x003b1;&#x02013;stimulated HMEC-1 monolayers or to immobilized intercellular adhesion molecule-1 (ICAM-1). SIRP&#x003b1; overexpression also reduced MCP-1&#x02013;initiated migration of THP-1 cells across TNF&#x003b1;&#x02013;stimulated HMEC-1 monolayers. Furthermore, &#x003b2;<sub>2</sub> integrin-mediated THP-1 cell spreading and actin polymerization in response to MCP-1, and phagocytosis of bacteria were both inhibited by SIRP&#x003b1; overexpression.</p></sec><sec><title>Conclusions/Significance</title><p>SIRP&#x003b1; negatively regulates &#x003b2;<sub>2</sub> integrin-mediated monocyte adhesion, transendothelial migration and phagocytosis, thus may serve as a critical molecule in preventing excessive activation and accumulation of monocytes in the arterial wall during early stage of atherosclerosis.</p></sec></abstract><counts><page-count count="8"/></counts></article-meta></front><body><sec id="s1"><title>Introduction</title><p>Recruitment of monocytes from circulation to inflamed tissues plays a pivotal role in the initiation and progression of atherosclerosis <xref ref-type="bibr" rid="pone.0003291-Gerrity1">&#x0005b;1&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0003291-Ross1">&#x0005b;2&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0003291-Rosenfeld1">&#x0005b;3&#x0005d;</xref>. After migrated to lesion region, monocytes are rapidly differentiated into macrophage which engulf lipids and form the fatty streak <xref ref-type="bibr" rid="pone.0003291-Boisvert1">&#x0005b;4&#x0005d;</xref>. Although the mechanisms that govern the delivery of monocytes from circulation to inflammatory site are not fully understood, the process of monocyte diapedesis has been regarded as a multi-step event that is sequentially regulated by a panel of adhesion molecules and signaling pathways. E- and P-selectins are involved in the initial reversible adherence of monocytes to the endothelial cell monolayers <xref ref-type="bibr" rid="pone.0003291-Dong1">&#x0005b;5&#x0005d;</xref>. The following firm adhesion is mediated by monocyte &#x003b2;<sub>2</sub> integrins,including CD11a/CD18 and CD11b/CD18,that recognize vascular cell adhesion molecule-1(VCAM-1) and intercellular adhesion molecule-1 (ICAM-1) on endothelial cells <xref ref-type="bibr" rid="pone.0003291-Springer1">&#x0005b;6&#x0005d;</xref>. Firm adhesion of monocytes requires activation of integrins, which can be triggered by agonist-induced activation of G protein&#x02013;coupled chemokine receptors <xref ref-type="bibr" rid="pone.0003291-Campbell1">&#x0005b;7&#x0005d;</xref>. Monocytes express CC chemokine receptor 2 (CCR2), which binds monocyte chemoattractant protein-1 (MCP-1), leading to &#x003b2;<sub>2</sub> integrin-mediated firm adhesion and subsequent transmigration of adhered monocytes through the vascular endothelium <xref ref-type="bibr" rid="pone.0003291-Han1">&#x0005b;8&#x0005d;</xref>.</p><p>Recently signal regulatory protein &#x003b1; (SIRP&#x003b1;) (also designate as SHPS-1<xref ref-type="bibr" rid="pone.0003291-Oshima1">&#x0005b;9&#x0005d;</xref>, p84<xref ref-type="bibr" rid="pone.0003291-Jiang1">&#x0005b;10&#x0005d;</xref>, BIT<xref ref-type="bibr" rid="pone.0003291-Timms1">&#x0005b;11&#x0005d;</xref>, MFR<xref ref-type="bibr" rid="pone.0003291-Saginario1">&#x0005b;12&#x0005d;</xref>, MyD-1<xref ref-type="bibr" rid="pone.0003291-Patel1">&#x0005b;13&#x0005d;</xref>, etc.) has been reported to serve as an important modulator for controlling leukocyte inflammatory responses <xref ref-type="bibr" rid="pone.0003291-Barclay1">&#x0005b;14&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0003291-Liu1">&#x0005b;15&#x0005d;</xref>. As an immunoglobulin superfamily member (IgSF), SIRP&#x003b1; is expressed mainly by myeloid. SIRP&#x003b1; has a long intracellular domain that contains four tyrosine residues to form two immunoreceptor tyrosine-based inhibition motifs (ITIMs) and this type of signaling structure is highly conserved between mice, rats and humans. Studies have suggested that binding of SIRP&#x003b1; with its extracellular ligand CD47 results in phosphorylations of SIRP&#x003b1; ITIMs, which in turn, leads to their association with SH2-domain-containing protein tyrosine phosphotases SHP-1 and SHP-2 <xref ref-type="bibr" rid="pone.0003291-Fujioka1">&#x0005b;16&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0003291-Kharitonenkov1">&#x0005b;17&#x0005d;</xref> to delivers signals that regulate a variety of cellular functions <xref ref-type="bibr" rid="pone.0003291-Barclay1">&#x0005b;14&#x0005d;</xref>. Ligation of SIRP&#x003b1; by antibody or CD47 recombinant inhibits many leukocyte functions, including phagocytosis<xref ref-type="bibr" rid="pone.0003291-Yamao1">&#x0005b;18&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0003291-Okazawa1">&#x0005b;19&#x0005d;</xref>, tumour-necrosis factor production<xref ref-type="bibr" rid="pone.0003291-Smith1">&#x0005b;20&#x0005d;</xref> and <italic>in vitro</italic> transmigration<xref ref-type="bibr" rid="pone.0003291-Liu2">&#x0005b;21&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0003291-deVries1">&#x0005b;22&#x0005d;</xref>. Activation of SIRP&#x003b1; by arterial elastic laminae also inhibits monocyte adhesion<xref ref-type="bibr" rid="pone.0003291-Liu3">&#x0005b;23&#x0005d;</xref>. Fibroblasts expressing a SIRP&#x003b1; mutant lacking ITIMs-containing cytoplasmic tail showed increased formation of focal adhesions and actin stress fibres in response to interaction with extracellular matrix, suggesting that SIRP&#x003b1; also plays a role in integrin-mediated cytoskeletal organization <xref ref-type="bibr" rid="pone.0003291-Inagaki1">&#x0005b;24&#x0005d;</xref>. Negative regulatory role of SIRP&#x003b1; has also been found in tumor metastasis, survival, and cell transformation <xref ref-type="bibr" rid="pone.0003291-Wu1">&#x0005b;25&#x0005d;</xref>.</p><p>In the present study, to further explore the negative regulatory role of SIRP&#x003b1; in various functional aspects of monocytes, we examined the correlation between expression level of SIRP&#x003b1; in THP-1 cells and THP-1 cell transmigratory capacity. By overexpressing SIRP&#x003b1; in THP-1 cells, we also determined the alteration of &#x003b2;<sub>2</sub> integrin expression and &#x003b2;<sub>2</sub> integrins-mediated cellular functions of monocytes in response to chemoattractant stimulation.</p></sec><sec sec-type="materials|methods" id="s2"><title>Materials and Methods</title><sec id="s2a"><title>Reagents and Antibodies</title><p>Recombinant human MCP-1 and TNF&#x003b1;, were purchased from PeproTech (Rocky Hill, NJ). AGEs-BSA (AGEs) was prepared according to a method previously described <xref ref-type="bibr" rid="pone.0003291-Valcourt1">&#x0005b;26&#x0005d;</xref>. Briefly, 50 mg/ml bovine serum albimin (BSA) (Fraction V, sterile filtered, Sigma-Aldrich) was incubated with 0.6 M D-ribose or 0.5 M D-glucose and 0.3 M lysine in PBS containing 100 units/ml penicillin and streptomycin for 4 weeks. The unincorporated sugars were removed by dialysis against PBS. Polyclonal anti-human CD11b were generated against C-terminal peptide of CD11b <xref ref-type="bibr" rid="pone.0003291-Zen1">&#x0005b;27&#x0005d;</xref>. Polyclonal anti-SIRP&#x003b1; antibody (SIRP&#x003b1;-ct) was obtained from Chemicon (Temecula, CA). Monoclonal anti-CD11b (OKM-1), and anti-CD11a (TIB-217), prepared in our laboratory from hybridoma, were obtained from American Type Culture Collection (ATCC) (Manassas, VA). Monoclonal anti-CD11c (S-HCL-3, IgG2b) and anti-CCR2 (clone 48607) were obtained from BD Biosciences (San Diego, CA).</p></sec><sec id="s2b"><title>Cells</title><p>THP-1 cells (Chinese Cell Culture Center, Shanghai, China) were cultured and maintained as described <xref ref-type="bibr" rid="pone.0003291-Han1">&#x0005b;8&#x0005d;</xref>. In separated experiments, THP-1 cells were treated with AGEs-BSA (AGEs) at various concentrations overnight. Cells treated with BSA of the same concentration served as controls. Immortalized HMEC-1 was kindly provided by Dr. E.W. Ades (Centers for Disease Control and Prevention, Atlanta, GA)<xref ref-type="bibr" rid="pone.0003291-Ades1">&#x0005b;28&#x0005d;</xref> and were grown in MCDB-131 (Invitrogen) supplemented with 10 ng/ml epidermal growth factor (Becton-Dickinson), 1 &#x000b5;g/ml hydrocortisone (Sigma-Aldrich) and 10&#x02013;15&#x00025; fetal bovine serum (Hyclone). HMEC-1 cells were seeded on collagen (Sigma-Aldrich)-coated tissue culture plates or permeable Transwell filters (5.0 &#x000b5;m pore size, 0.33 cm<sup>2</sup> surface areas, Costar, NY).</p></sec><sec id="s2c"><title>SIRP&#x003b1; Overexpression</title><p>Complete sequence of human SIRP&#x003b1; was amplified, inserted into the expression vector pcDNA3.1 (Invitrogen, Carlsbad, CA), and confirmed by DNA sequencing. The transfection of THP-1 cells was conducted via Lipofectmin 2000 (Invitrogen). Briefly, Lipofectmin-SIRP&#x003b1; pcDNA3.1 complex (250 &#x000b5;L) was added dropwise to 5&#x000d7;10<sup>6</sup> THP-1 cells in 20 mL RPMI medium 1640 containing 2&#x00025; heat-inactivated fetal bovine serum. After 24 h incubation, THP-1 cells were harvested and used for further analysis.</p></sec><sec id="s2d"><title>Immunofluorescence, Confocal Microscopy and Flow Cytometry</title><p>Surface expressions of &#x003b2;<sub>2</sub>-integrins were detected using flow cytometry as described <xref ref-type="bibr" rid="pone.0003291-Han1">&#x0005b;8&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0003291-Zen2">&#x0005b;29&#x0005d;</xref>. The relative surface expression was estimated by subtracting the mean fluorescence intensity (MFI) of cells labeled with the nonspecific antibody from that of cells labeled with the antibodies detecting &#x003b2;<sub>2</sub>-integrins. All studies consisted of at least three independent experiments. Flow cytometry was performed and data were analyzed using CELLQUEST software (BD Biosciences). The polymerization of actin filaments in THP-1 cells, induced by pretreatment with 10 nM MCP-1 or 25 ng/mL TNF&#x003b1; for 30&#x02013;60 minutes, was determined using rhodamine-conjugated phalloidin staining (Molecular Probes) according to the manufacturer's protocol. Briefly, cells treated with cytokines were fixed with 3.7&#x00025; paraformaldehyde in PBS for 5 minutes, gently permeabilized with 0.1&#x00025; Triton X-100, and blocked with 1&#x00025; BSA in PBS for 30 min followed by rhodamine-conjugated phalloidin staining. In some experiments, cells were treated with cytochalasin D (Sigma-Aldrich) to inhibit actin polymerization <xref ref-type="bibr" rid="pone.0003291-Ryu1">&#x0005b;30&#x0005d;</xref>. Coverslips were mounted with antifade mounting medium (Molecular Probes). Images were captured and analyzed by a laser scanning confocal microscope equipped with an image processing system (Olympus Microsystems).</p></sec><sec id="s2e"><title>Cell Adhesion Assays</title><p>Confluent HMEC-1 cell monolayers cultured on gelatin (Difco)&#x02013;coated tissue culture plates or permeable Transwell filters. Monolayers were treated with 25 ng/mL TNF&#x003b1; for 6 h to induce VCAM-1 and ICAM-1 expression prior to the adhesion assay <xref ref-type="bibr" rid="pone.0003291-Luscinskas1">&#x0005b;31&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0003291-Zhang1">&#x0005b;32&#x0005d;</xref>. In separate experiments, 24-well plates were coated for 2 h with 10 &#x000b5;g/mL human recombinant VCAM-1 or ICAM-1. THP-1 cells were briefly labeled with 2&#x02032;,7&#x02032;-bis-(2-carboxyethyl)-6-carboxyfluorescein acetoxymethyl ester (BCECF-AM, Molecular Probes)<xref ref-type="bibr" rid="pone.0003291-Zen1">&#x0005b;27&#x0005d;</xref> and then suspended in RPMI 1640 medium containing 0.1&#x00025; BSA and stimulated with 10 nM MCP-1 for 30 min to activate integrins <xref ref-type="bibr" rid="pone.0003291-Ryu1">&#x0005b;30&#x0005d;</xref>. In a subset of experiments, monocytes were pre-incubated with 50 &#x000b5;M dibutyl-cAMP (Bt2cAMP) for 30 min to inhibit chemokine-mediated integrin activation. Fluorescently labeled monocytes (&#x0223c;2&#x000d7;10<sup>5</sup> cells/well) were then added to HMEC-1 monolayers or 24-well plates coated with VCAM-1 or ICAM-1, and incubated for 30 min at 37&#x000b0;C. Nonadherent monocytes were removed by gentle washing with PBS and the bound cells were measured by a fluorescence plate reader at excitation/emission wavelengths of 485/535 nm (Millipore, Milford, MA)<xref ref-type="bibr" rid="pone.0003291-Zen1">&#x0005b;27&#x0005d;</xref>.</p></sec><sec id="s2f"><title>Transendothelial Migration (TEM)</title><p>Migration of THP-1 cells across TNF&#x003b1;&#x02013;pre-activated HMEC-1 monolayers was performed as previously described <xref ref-type="bibr" rid="pone.0003291-Ryu1">&#x0005b;30&#x0005d;</xref> with minor modification. Prior to migration assay, HMEC-1 monolayers cultured on gelatin (Difco)&#x02013;coated transwell filters were treated with 25 ng/mL TNF&#x003b1; for 6 h. THP-1 cells (5.0&#x000d7;10<sup>5</sup>/per well) were added to the upper chamber of Transwell inserts containing 200 &#x000b5;l HBSS. 700 &#x000b5;l HBSS containing 10 nM MCP-1 was placed in the bottom chamber. After 90 min and 180 min incubation at 37&#x000b0;C under 5&#x00025; CO<sub>2</sub>, cells that had transmigrated to the lower chamber were harvested in 1 ml PBS containing 0.1&#x00025; BSA and labeled with phycoerythrin (PE)-conjugated anti-human CD14 antibody. 10<sup>6</sup> FITC-conjugated standard beads (PharMingen, La Jolla, CA) were added to the cell suspension and the number of THP-1 cells was counted until 10,000 beads were counted by flow cytometry. All experiments were repeated as triplicated fashion in at least three independent studies.</p></sec><sec id="s2g"><title>Phagocytosis of Fluorescein Conjugated Bacteria</title><p>THP-1 cells transfected with SIRP&#x003b1; or Mock vector were incubated for 3 h with 100 &#x000b5;l of fluorescein-conjugated <italic>E. coli</italic> K-12 bioparticles (Molecular Probes) <xref ref-type="bibr" rid="pone.0003291-Sharlow1">&#x0005b;33&#x0005d;</xref>. The <italic>E. coli</italic> suspension was aspirated, and after three washes with Hank's balanced salt solution devoid of Ca<sup>2&#x0002b;</sup> and Mg<sup>2&#x0002b;</sup> (HBSS<sup>&#x02212;</sup>), cell associated fluorescence was observed under microscopy or measured using a SpectraMax microtiter plate reader (Molecular Devices).</p></sec><sec id="s2h"><title>Western Blot</title><p>THP-1 cells were solubilized in lysis buffer containing 1&#x00025; Triton X-100 and a panel of protease inhibitors at 4&#x000b0;C. Pellet was removed after centrifuged at 13,000&#x000d7;<italic>g</italic> for 5 minutes. Supernatant was normalized for total protein, and loaded on 10&#x00025; SDS-PAGE. After electrophoresis and transfer onto Hybond membranes, membranes were blocked with 5&#x00025; non-fat milk. Antigens were detected using suitable primary antibodies followed by incubation with HRP-conjugated antibodies and ECL (Amersham) detection.</p></sec><sec id="s2i"><title>Statistical Analysis</title><p>Data were analyzed by the Student <italic>t</italic> test; P values of &#x0003c;0.05 were regarded as significant differences (&#x0002a;, p&#x0003c;0.05; &#x0002a;&#x0002a;, p&#x0003c;0.01).</p></sec></sec><sec id="s3"><title>Results</title><sec id="s3a"><title>Downregulation of SIRP&#x003b1; in THP-1 cells is correlated with enhanced &#x003b2;<sub>2</sub> integrin-mediated cell adhesion</title><p>It has been reported that advanced glycation end products (AGEs) are involved in tissue damage associated with diabetic complications and aging <xref ref-type="bibr" rid="pone.0003291-Miyata1">&#x0005b;34&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0003291-Peppa1">&#x0005b;35&#x0005d;</xref>. Although the mechanism is still not clear, monocytes tend to be activated by AGEs and show an enhanced chemotaxis under such inflammatory conditions. As shown by Western blot analysis in <xref ref-type="fig" rid="pone-0003291-g001">Figure 1A</xref>, the expression of SIRP&#x003b1; in THP-1 cells was decreased after AGEs treatment. Served as controls, &#x003b2;-actin level was not altered. The down-regulation of SIRP&#x003b1; in AGEs&#x02013;treated THP-1 cells is contrast to that of receptor for advanced glycation end products (RAGE) and junctional adhesion molecule-like protein (JAML), which expression levels are both increased after AGEs treatment (Zen et al, unpublished). <xref ref-type="fig" rid="pone-0003291-g001">Fig. 1B</xref> showed the quantitative analysis of SIRP&#x003b1; downregulation by AGEs in a dose-dependent fashion. Interestingly, AGEs&#x02013;treated THP-1 cells showed a significant enhanced cell surface expression of &#x003b2;<sub>2</sub> integrins, in particular CD11b/CD18, in response to the stimulation of MCP-1 (<xref ref-type="fig" rid="pone-0003291-g001">Fig. 1C</xref>). Also, compared to BSA&#x02013;treated THP-1 cells, AGEs&#x02013; treated THP-1 cells had a higher percentage of cell adhesion to TNF&#x003b1;&#x02013;activated HMEC-1 monolayer (<xref ref-type="fig" rid="pone-0003291-g001">Fig. 1D</xref>). In response to MCP-1, AGEs&#x02013;treated THP-1 cells also showed an increased transmigration across TNF&#x003b1;&#x02013;activated HMEC-1 monolayers compared to THP-1 cells treated with BSA (<xref ref-type="fig" rid="pone-0003291-g001">Fig. 1E</xref>). Together, these results suggest that AGEs treatment can activate THP-1 cells and enhance cell chemotaxis.</p><fig id="pone-0003291-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0003291.g001</object-id><label>Figure 1</label><caption><title>Down-regulation of SIRP&#x003b1; in THP-1 cells treated with BSA-AGEs is correlated to enhanced THP-1 cell surface expression of leukocyte &#x003b2;<sub>2</sub> integrins and &#x003b2;<sub>2</sub> integrins-mediated THP-1 cell inflammatory responses.</title><p>In these experiments, THP-1 cells were treated with BSA-AGEs (AGEs) or BSA overnight at 37&#x000b0;C. A: SIRP&#x003b1; protein level in THP-1 cells; B: reduction of SIRP&#x003b1; protein level by AGEs in dose-dependent fashion; C: Cell surface expression level of &#x003b2;<sub>2</sub> integrins in THP-1 cells; D and E: THP-1 cell adhesion to and migration across TNF&#x003b1;&#x02013;pre-activated HMEC-1 monolayers, respectively. All data are mean&#x000b1;SD (<italic>n</italic>&#x0200a;&#x0003d;&#x0200a;3) of three independent experiments.</p></caption><graphic xlink:href="pone.0003291.g001"/></fig></sec><sec id="s3b"><title>Overexpression of SIRP&#x003b1; in THP-1 cells inhibits MCP-1&#x02013;induced cell surface expression of &#x003b2;2 integrins</title><p>To define the role of SIRP&#x003b1; in regulating monocyte inflammatory response, we characterized the alteration of &#x003b2;<sub>2</sub> integrin expression and &#x003b2;<sub>2</sub> integrin-mediated cell adhesion, migration and phagocytosis in THP-1 cells after significantly increase SIRP&#x003b1; expression level. As shown in <xref ref-type="fig" rid="pone-0003291-g002">Figure 2A</xref>, immunoblot analysis showed that the delivery of the pcDNA3.1 vector encoding human SIRP&#x003b1; into THP-1 cells profoundly enhanced SIRP&#x003b1; expression. Compared to mock&#x02013;transfected THP-1 cells, SIRP&#x003b1;&#x02013;transfected THP-1 cells also showed a significantly enhanced expression of SIRP&#x003b1; on cell surface, as indicated by flow cytometry (<xref ref-type="fig" rid="pone-0003291-g002">Fig. 2B</xref>).</p><fig id="pone-0003291-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0003291.g002</object-id><label>Figure 2</label><caption><title>SIRP&#x003b1; overexpression in THP-1 cells and its effect on cell surface expression of &#x003b2;<sub>2</sub> integrins and CCR2.</title><p>THP-1 cells were transfected with the empty pcDNA3.1 vector (Mock) or the SIRP&#x003b1;-encoding pcDNA3.1 vector (SIRP&#x003b1;). A: SIRP&#x003b1; protein level in SIRP&#x003b1;&#x02013; or mock&#x02013; transfected THP-1 cells; B: Cell surface SIRP&#x003b1; expression in Mock&#x02013; and SIRP&#x003b1;&#x02013;transfected THP-1 cells; C: THP-1 cell surface expression of CD11a, CD11b, CD11c and CCR2. Note that SIRP&#x003b1; overexpression significantly suppressed MCP-1&#x02013;induced up-regulation of THP-1 surface expression of CD11b and CD11a but not CCR2, and that SIRP&#x003b1; overexpression did not affect the basal level of &#x003b2;<sub>2</sub> integrins. All data are mean&#x000b1;SD of three independent experiments.</p></caption><graphic xlink:href="pone.0003291.g002"/></fig><p>Similar to circulating monocytes, THP-1 cells normally express &#x003b2;<sub>2</sub> integrins <xref ref-type="bibr" rid="pone.0003291-Han1">&#x0005b;8&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0003291-Schober1">&#x0005b;36&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0003291-Simon1">&#x0005b;37&#x0005d;</xref> and their cell surface expression levels are rapidly up-regulated by chemoattractants during inflammatory response. We next determined the alteration of cell surface expression of CD11b/CD18 and CD11a/CD18 in SIRP&#x003b1;&#x02013; or mock&#x02013;transfected THP-1 cells. In these experiments, SIRP&#x003b1;&#x02013; or mock&#x02013;transfected THP-1 cells were treated with or without 10 nM MCP-1 for 30 min and then directly labeled with PE-conjugated mouse IgG specific for human CD11a, CD11b, and CC chemokine receptor 2 (CCR2), and surface expression was analyzed using flow cytometry. The results showed that SIRP&#x003b1; overexpression in THP-1 cells did not affect the basal level of &#x003b2;<sub>2</sub> integrin expression on cell surface but significantly reduced the up-regulation of cell surface &#x003b2;<sub>2</sub> integrin expression by MCP-1 (<xref ref-type="fig" rid="pone-0003291-g002">Fig. 2C</xref>).</p></sec><sec id="s3c"><title>SIRP&#x003b1; overexpression affects CD11b/CD18-mediated THP-1 cell functions in response to MCP-1 stimulation</title><p>Chemokines such as MCP-1 has been reported to trigger integrin&#x02013;mediated firm adhesion and subsequent transmigration of monocytes <xref ref-type="bibr" rid="pone.0003291-Han1">&#x0005b;8&#x0005d;</xref>. As shown in <xref ref-type="fig" rid="pone-0003291-g003">Figure 3A</xref>, MCP-1&#x02013;stimulated THP-1 cells showed a significant integrin-mediated firm adhesion to TNF&#x003b1;&#x02013;activated HMEC-1 monolayers. However, this firm adhesion was largely reduced in THP-1 cells with SIRP&#x003b1; overexpression. Since TNF&#x003b1;&#x02013;stimulated HMEC-1 monolayers express both VCAM-1 and ICAM-1, the specific ligands for &#x003b2;<sub>1</sub> and &#x003b2;<sub>2</sub> integrins, respectively, additional adhesion assays were performed using plates coated with human recombinant ICAM-1 or VCAM-1, respectively. To estimate background adhesion, control adhesion assays were performed using THP-1 cells pretreated with Bt2cAMP, a permeable analogue of cAMP that blocks integrin-dependent firm adhesion triggered by MCP-1 <xref ref-type="bibr" rid="pone.0003291-Ryu1">&#x0005b;30&#x0005d;</xref>. SIRP&#x003b1;&#x02013;transfected THP-1 cells did not show MCP-1&#x02013;induced firm adhesion to plates coated with ICAM-1, while adhesion to plates coated with VCAM-1 was intact (<xref ref-type="fig" rid="pone-0003291-g003">Fig. 3B</xref>).</p><fig id="pone-0003291-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0003291.g003</object-id><label>Figure 3</label><caption><title>SIRP&#x003b1; overexpression in THP-1 cells decreases MCP-1&#x02013;stimulated adhesion.</title><p>A: Micrographs and histograms show THP-1 cells adhered to HMEC-1 monolayers. Bar&#x0200a;&#x0003d;&#x0200a;20 &#x000b5;m. B: MCP-1&#x02013;dependent adhesion of SIRP&#x003b1;&#x02013; or mock&#x02013;transfected THP1 monocytes to plates coated with ICAM-1 or VCAM-1. In separate experiments, monocytes were pretreated with 50 &#x000b5;M Bt2cAMP to determine background integrin-independent nonspecific adhesion. All data are mean&#x000b1;SD (<italic>n</italic>&#x0200a;&#x0003d;&#x0200a;3) of three independent experiments.</p></caption><graphic xlink:href="pone.0003291.g003"/></fig><p>Previous studies have reported that chemokine-mediated activation of &#x003b2;<sub>2</sub> integrins was essential for THP-1 cell adhesion and subsequent transmigration through endothelial monolayers <xref ref-type="bibr" rid="pone.0003291-Campbell1">&#x0005b;7&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0003291-Han1">&#x0005b;8&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0003291-Sotiriou1">&#x0005b;38&#x0005d;</xref>. Therefore, the effect of SIRP&#x003b1; overexpression on transendothelial migration (TEM) of THP-1 cells was examined by transmigration assay. In mock-transfected THP-1 cells, MCP-1 triggered strong THP-1 cell migration across HMEC-1 monolayers. As shown in <xref ref-type="fig" rid="pone-0003291-g004">Figure 4</xref>, more than 20&#x00025; of total applied THP-1 cells were migrated across TNF&#x003b1;&#x02013;activated HMEC-1 monolayers after 3 h incubation. In contrast, MCP-1&#x02013;triggered transmigration of THP-1 cells that were overexpressed with SIRP&#x003b1; was strongly reduced (<xref ref-type="fig" rid="pone-0003291-g004">Fig. 4</xref>). In both mock-transfected and SIRP&#x003b1; overexpressed THP-1 cells, spontaneous migration of THP-1 cells in the absence of MCP-1 was minimal (data not shown).</p><fig id="pone-0003291-g004" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0003291.g004</object-id><label>Figure 4</label><caption><title>SIRP&#x003b1; overexpression reduces the MCP-1&#x02013;induced migration of THP-1 cells across HMEC-1 monolayers pre-activated with 25 ng/mL TNF&#x003b1;.</title><p>All data are mean&#x000b1;SD (<italic>n</italic>&#x0200a;&#x0003d;&#x0200a;3) of three independent experiments.</p></caption><graphic xlink:href="pone.0003291.g004"/></fig><p>Leukocyte &#x003b2;<sub>2</sub> integrin&#x02013;mediated cell firm adhesion initiates cell shape changes and spreading of monocytes, events that must occur for subsequent cellular locomotion and transmigration. Next we investigated the effect of SIRP&#x003b1; overexpression on TNF&#x003b1;&#x02013; and MCP-1&#x02013;stimulated actin polymerization and cell spreading in THP-1 cells. SIRP&#x003b1;&#x02013; or mock&#x02013; transfected THP-1 cells were stimulated with TNF&#x003b1; or MCP-1 for 30 minutes, then fixed, and labeled with rhodamine-conjugated phalloidin to visualize actin filaments. As a control, mock&#x02013;transfected THP-1 cells were pretreated with cytochalasin D to inhibit actin polymerization <xref ref-type="bibr" rid="pone.0003291-Mateo1">&#x0005b;39&#x0005d;</xref>. Labeled monocytes were mounted on coverslips and images were obtained using confocal microscopy. As shown in <xref ref-type="fig" rid="pone-0003291-g005">Figure 5</xref>, confocal microscope images showed that mock&#x02013; transfected THP-1 cells exposed to TNF&#x003b1; or MCP-1 underwent morphological changes resulting in multiple pseudopods (arrowheads) with abundant actin filaments, and that this process was inhibited by cytochalasin D. In contrast, significantly less TNF&#x003b1;&#x02013; or MCP-1&#x02013;stimulated actin polymerization and cell spreading had occurred in THP-1 cells with SIRP&#x003b1; overexpression (<xref ref-type="fig" rid="pone-0003291-g005">Fig. 5</xref>).</p><fig id="pone-0003291-g005" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0003291.g005</object-id><label>Figure 5</label><caption><title>TNF&#x003b1; and MCP-1&#x02013;induced cell spreading and actin polymerization in THP-1 cells.</title><p>SIRP&#x003b1;&#x02013; or mock&#x02013;transfected THP-1 cells were stimulated with TNF&#x003b1; or MCP-1 for 30 minutes, fixed, and labeled with rhodamine-conjugated phalloidin to visualize actin filaments. As a negative control, mock&#x02013;transfected THP-1 cells were pretreated with cytochalasin D (Mock&#x0002b;Cyt. D). Bar&#x0200a;&#x0003d;&#x0200a;20 &#x000b5;m.</p></caption><graphic xlink:href="pone.0003291.g005"/></fig><p>The phagocytic function of THP-1 cells is also dependent on &#x003b2;<sub>2</sub> integrins <xref ref-type="bibr" rid="pone.0003291-Gafa1">&#x0005b;40&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0003291-Shi1">&#x0005b;41&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0003291-Capo1">&#x0005b;42&#x0005d;</xref>. Next we examined the effect of SIRP&#x003b1; overexpression on the capacity of THP-1 cells to engulf fluorescein&#x02013;labeled <italic>E. coli</italic> K12 bioparticles. As shown by confocal images in <xref ref-type="fig" rid="pone-0003291-g006">Figure 6A</xref>, the mock-transfected THP-1 cells showed a significant phagocytosis of fluorescein&#x02013;conjugated bacteria particles after 3 h incubation (<xref ref-type="fig" rid="pone-0003291-g006">Fig. 6A</xref>, arrows), while in SIRP&#x003b1;&#x02013;transfected THP-1 cells, uptake of fluorescein&#x02013;conjugated bacteria particles was strongly reduced. The quantitative analysis of uptaking fluorescein&#x02013;conjugated bacteria particles by THP-1 cells was shown in <xref ref-type="fig" rid="pone-0003291-g006">Figure 6B</xref>. Taken together, these results clearly show that SIRP&#x003b1; overexpression in THP-1 cells reduces various inflammatory responses mediated by leukocyte &#x003b2;<sub>2</sub> integrins.</p><fig id="pone-0003291-g006" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0003291.g006</object-id><label>Figure 6</label><caption><title>SIRP&#x003b1; overexpression in THP-1 cells impairs cell phagocytic function.</title><p>Fluorescently labeled bacteria were incubated with SIRP&#x003b1;&#x02013; or mock&#x02013;transfected THP-1 cells for 3 h. A: Images of phagocytosis of bacteria by THP-1 cells; B: Quantitative analysis of bacteria phagocytosis by THP-1 cells. Bar&#x0200a;&#x0003d;&#x0200a;20 &#x000b5;m. All data are mean&#x000b1;SD (<italic>n</italic>&#x0200a;&#x0003d;&#x0200a;4) of four independent experiments.</p></caption><graphic xlink:href="pone.0003291.g006"/></fig></sec></sec><sec id="s4"><title>Discussion</title><p>Recent studies have demonstrated that SIRP&#x003b1; is involved in regulating various inflammatory responses of leukocytes, in particular leukocyte chemotaxis and phagocytosis. By studying the leukocyte &#x003b2;<sub>2</sub> integrin-mediated functional changes in THP-1 cells after downregulation or overexpression of SIRP&#x003b1; level, we show that SIRP&#x003b1; negatively regulates &#x003b2;<sub>2</sub> integrin-mediated THP-1 cell inflammatory responses, such as adhesion, transendothelial migration and phagocytosis.</p><sec id="s4a"><title>Correlation between SIRP&#x003b1; protein level and CD11b/CD18-mediated cellular functions in THP-1 cells</title><p>Ligation of SIRP&#x003b1; with its extracellular ligand CD47 results in phosphorylations of SIRP&#x003b1; ITIMs, which in turn, leads to their association with SH2-domain-containing protein tyrosine phosphotases SHP-1 and SHP-2 <xref ref-type="bibr" rid="pone.0003291-Fujioka1">&#x0005b;16&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0003291-Kharitonenkov1">&#x0005b;17&#x0005d;</xref> to delivers signals that regulate a variety of cellular functions <xref ref-type="bibr" rid="pone.0003291-Barclay1">&#x0005b;14&#x0005d;</xref>. Binding of SIRP&#x003b1; by antibody or CD47 recombinant inhibits many leukocyte functions, including phagocytosis <xref ref-type="bibr" rid="pone.0003291-Yamao1">&#x0005b;18&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0003291-Okazawa1">&#x0005b;19&#x0005d;</xref>, tumour-necrosis factor production <xref ref-type="bibr" rid="pone.0003291-Smith1">&#x0005b;20&#x0005d;</xref> and <italic>in vitro</italic> transmigration <xref ref-type="bibr" rid="pone.0003291-Liu2">&#x0005b;21&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0003291-deVries1">&#x0005b;22&#x0005d;</xref>. Activation of SIRP&#x003b1; by arterial elastic laminae also inhibits monocyte adhesion <xref ref-type="bibr" rid="pone.0003291-Liu3">&#x0005b;23&#x0005d;</xref>. Fibroblasts expressing a SIRP&#x003b1; mutant lacking ITIMs-containing cytoplasmic tail showed increased formation of focal adhesions and actin stress fibres in response to interaction with extracellular matrix, suggesting that SIRP&#x003b1; is also involved in mediating outside-in signal transduction during cell-matrix interaction. Using THP-1 cell as model cell line, here we show that SIRP&#x003b1; protein level is downregulated by AGEs treatment, which is also correlated to an enhanced cell surface expression of &#x003b2;<sub>2</sub> integrins and &#x003b2;<sub>2</sub> integrins-mediated cell adhesion (<xref ref-type="fig" rid="pone-0003291-g001">Fig. 1</xref>). The finding of SIRP&#x003b1; reduction in AGEs-treated THP-1 cells is supported by a recent report that mouse macrophages have lower SIRP&#x003b1; expression level following LPS stimulation <xref ref-type="bibr" rid="pone.0003291-Kong1">&#x0005b;43&#x0005d;</xref>. The correlation between SIRP&#x003b1; expression level and chemoattractant-induced cell surface upregulation of &#x003b2;<sub>2</sub> integrins and &#x003b2;<sub>2</sub> integrins-mediated THP-1 cell inflammatory responses is further characterized in THP-1 cells overexpressed with SIRP&#x003b1; (<xref ref-type="fig" rid="pone-0003291-g002">Fig. 2</xref>&#x02013;<xref ref-type="fig" rid="pone-0003291-g003"/><xref ref-type="fig" rid="pone-0003291-g004"/><xref ref-type="fig" rid="pone-0003291-g005"/><xref ref-type="fig" rid="pone-0003291-g006">6</xref>). The results not only confirm the inhibitory function of SIRP&#x003b1; on THP-1 inflammatory responses, but also indicated that the role of SIRP&#x003b1; in THP-1 cells is through affecting the functions of &#x003b2;<sub>2</sub> integrins, particularly CD11b/CD18. It is worthy to note that overexpression of SIRP&#x003b1; does not alter the basal level of &#x003b2;<sub>2</sub> integrin expression but the upregulation of &#x003b2;<sub>2</sub> integrins by MCP-1 stimulation, suggesting that SIRP&#x003b1; is one of essential molecules along the signal pathways that may regulate the synthesis, transportation and translocation process of &#x003b2;<sub>2</sub> integrins. Moreover, if AGEs and other inflammatory factors can affect &#x003b2;<sub>2</sub> integrin expression and function through down-regulating SIRP&#x003b1;, it might be reasonable to conclude that SIRP&#x003b1; can mediate an inside-out signal in regulating &#x003b2;<sub>2</sub> integrin function.</p></sec><sec id="s4b"><title>SIRP&#x003b1; as a negative regulator in monocyte recruitment during inflammation</title><p>The expression of &#x003b2;<sub>2</sub> integrins and adhesion molecules in monocytes is regulated by chemokines such as MCP-1, SDF-1 alpha and RANTES <xref ref-type="bibr" rid="pone.0003291-Zhang1">&#x0005b;32&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0003291-Shahabuddin1">&#x0005b;44&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0003291-Papayannopoulou1">&#x0005b;45&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0003291-Weber1">&#x0005b;46&#x0005d;</xref>. The positive correlation between CD11b expression in circulating monocytes and the degree of monocyte infiltration into the proatherogenic vascular wall has been well-documented <xref ref-type="bibr" rid="pone.0003291-Han1">&#x0005b;8&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0003291-Aiello1">&#x0005b;47&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0003291-vanRoyen1">&#x0005b;48&#x0005d;</xref>. The increased expression of monocyte CD11b under pro-inflammatory conditions enhanced MCP-1&#x02013;mediated chemotaxis <italic>in vitro</italic><xref ref-type="bibr" rid="pone.0003291-Han1">&#x0005b;8&#x0005d;</xref>, induced excess monocyte adhesion to vascular endothelium, and increased formation of neointima and atherosclerotic plaques <xref ref-type="bibr" rid="pone.0003291-vanRoyen1">&#x0005b;48&#x0005d;</xref>. Although SIRP&#x003b1; overexpression did not affect surface expression of CCR2, the receptor for MCP-1, it resulted in a profound reduction of MCP-1&#x02013;mediated upregulation of THP-1 cell cell surface &#x003b2;<sub>2</sub> integrins and THP-1 cell TEM. In addition to reduction of CD11b and other &#x003b2;<sub>2</sub> integrins, our study has also demonstrated that overexpressing SIRP&#x003b1; in THP-1 cells display less cell spreading and actin polymerization in response to chemokine stimulation. The mechanism by which SIRP&#x003b1; modulates chemokine-induced cell spreading and actin polymerization is unknown although several possibilities exist: a) directly activates protein phosphatase and initiates signal pathways that attenuate filament actin polymerization and cell spreading, and b) binding to integrin-associated protein CD47 and modulating the integrin functions. Since SIRP&#x003b1; is a cellular ligand of CD47, which can augment the functions of integrins of the &#x003b2;<sub>1</sub>, &#x003b2;<sub>2</sub> and &#x003b2;<sub>3</sub> families via initiating heterotrimeric Gi protein signaling <xref ref-type="bibr" rid="pone.0003291-Brown1">&#x0005b;49&#x0005d;</xref>, thus modulating a range of cell activities including cell motility and adhesion, and leukocyte adhesion, migration and phagocytosis. Indeed, phagocytosis of bacteria by THP-1 cells, an event that is largely dependent on &#x003b2;<sub>2</sub> integrin and actin polymerization, was significantly reduced by overexpression of SIRP&#x003b1;. This result was in agreement with the previous finding that SIRP&#x003b1; contributes to down-regulating the macrophage phagocytic response <xref ref-type="bibr" rid="pone.0003291-Yamao1">&#x0005b;18&#x0005d;</xref>. In summary, the present study demonstrates for the first time that SIRP&#x003b1; overexpression potently inhibits the various inflammatory responses of THP-1 monocytes/macrophages mediated by &#x003b2;<sub>2</sub> integrins. The induction of SIRP&#x003b1; expression in THP-1 cells led to a reduction of chemokine-induced cell surface expression of &#x003b2;<sub>2</sub> integrins, which eventually resulted in less cell adhesion, cellular spreading, cell transmigration and phagocytosis. This observation suggests that SIRP&#x003b1; may function to decrease transendothelial migration of monocytes or other circulating leukocytes, reduce the burden of inflammatory cells in atheroma, and ultimately decrease plaque mass under atherogenic conditions. Since migration of monocytes across blood vessel lining endothelial monolayers is a key component during early stage of atherosclerosis, such an outcome would indicate that SIRP&#x003b1; overexpression in monocytes or macrophages has an anti-atherogenic effect and that SIRP&#x003b1; is a potential target in therapeutical implications.</p></sec></sec></body><back><ack><p>The authors thank Dr. E.W. Ades (Centers for Disease Control and Prevention, Atlanta, GA) and Dr. Yuan Liu (Department of Biology, Georgia State University, Atlanta, GA) for kindly gift of the immortalized HMEC-1 and SIRP&#x003b1; expression vectors, respectively. The authors also thank Mr. Bihn Ha and Ms Celia Chen for excellent technical assistance.</p></ack><ref-list><title>References</title><ref id="pone.0003291-Gerrity1"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gerrity</surname><given-names>RG</given-names></name></person-group><year>1981</year><article-title>The role of the monocyte in atherogenesis: I. Transition of blood-borne monocytes into foam cells in fatty lesions.</article-title><source>Am J Pathol</source><volume>103</volume><fpage>181</fpage><lpage>190</lpage><pub-id pub-id-type="pmid">7234961</pub-id></citation></ref><ref id="pone.0003291-Ross1"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ross</surname><given-names>R</given-names></name></person-group><year>1993</year><article-title>The pathogenesis of atherosclerosis: a perspective for the 1990s.</article-title><source>Nature</source><volume>362</volume><fpage>801</fpage><lpage>809</lpage><pub-id pub-id-type="pmid">8479518</pub-id></citation></ref><ref id="pone.0003291-Rosenfeld1"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rosenfeld</surname><given-names>ME</given-names></name></person-group><year>2002</year><article-title>Leukocyte recruitment into developing atherosclerotic lesions: the complex interaction between multiple molecules keeps getting more complex.</article-title><source>Arterioscler Thromb Vasc Biol</source><volume>22</volume><fpage>361</fpage><lpage>363</lpage><pub-id pub-id-type="pmid">11884275</pub-id></citation></ref><ref id="pone.0003291-Boisvert1"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Boisvert</surname><given-names>WA</given-names></name><name><surname>Santiago</surname><given-names>R</given-names></name><name><surname>Curtiss</surname><given-names>LK</given-names></name><name><surname>Terkeltaub</surname><given-names>RA</given-names></name></person-group><year>1998</year><article-title>A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice.</article-title><source>J Clin Invest</source><volume>101</volume><fpage>353</fpage><lpage>363</lpage><pub-id pub-id-type="pmid">9435307</pub-id></citation></ref><ref id="pone.0003291-Dong1"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>ZM</given-names></name><name><surname>Chapman</surname><given-names>SM</given-names></name><name><surname>Brown</surname><given-names>AA</given-names></name><name><surname>Frenette</surname><given-names>PS</given-names></name><name><surname>Hynes</surname><given-names>RO</given-names></name><etal/></person-group><year>1998</year><article-title>The combined role of P- and E-selectins in atherosclerosis.</article-title><source>J Clin Invest</source><volume>102</volume><fpage>145</fpage><lpage>152</lpage><pub-id pub-id-type="pmid">9649568</pub-id></citation></ref><ref id="pone.0003291-Springer1"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Springer</surname><given-names>TA</given-names></name></person-group><year>1994</year><article-title>Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm.</article-title><source>Cell</source><volume>76</volume><fpage>301</fpage><lpage>314</lpage><pub-id pub-id-type="pmid">7507411</pub-id></citation></ref><ref id="pone.0003291-Campbell1"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Campbell</surname><given-names>JJ</given-names></name><name><surname>Hedrick</surname><given-names>J</given-names></name><name><surname>Zlotnik</surname><given-names>A</given-names></name><name><surname>Siani</surname><given-names>MA</given-names></name><name><surname>Thompson</surname><given-names>DA</given-names></name><etal/></person-group><year>1998</year><article-title>Chemokines and the arrest of lymphocytes rolling under flow conditions.</article-title><source>Science</source><volume>279</volume><fpage>381</fpage><lpage>384</lpage><pub-id pub-id-type="pmid">9430588</pub-id></citation></ref><ref id="pone.0003291-Han1"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>KH</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Chang</surname><given-names>MK</given-names></name><name><surname>Han</surname><given-names>YC</given-names></name><name><surname>Park</surname><given-names>JH</given-names></name><etal/></person-group><year>2003</year><article-title>LDL activates signaling pathways leading to an increase in cytosolic free calcium and stimulation of CD11b expression in monocytes.</article-title><source>J Lipid Res</source><volume>44</volume><fpage>1332</fpage><lpage>1340</lpage><pub-id pub-id-type="pmid">12730301</pub-id></citation></ref><ref id="pone.0003291-Oshima1"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Oshima</surname><given-names>K</given-names></name><name><surname>Ruhul Amin</surname><given-names>AR</given-names></name><name><surname>Suzuki</surname><given-names>A</given-names></name><name><surname>Hamaguchi</surname><given-names>M</given-names></name><name><surname>Matsuda</surname><given-names>S</given-names></name></person-group><year>2002</year><article-title>SHPS-1, a multifunctional transmembrane glycoprotein.</article-title><source>FEBS Lett</source><volume>519</volume><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">12023008</pub-id></citation></ref><ref id="pone.0003291-Jiang1"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>P</given-names></name><name><surname>Lagenaur</surname><given-names>CF</given-names></name><name><surname>Narayanan</surname><given-names>V</given-names></name></person-group><year>1999</year><article-title>Integrin-associated protein is a ligand for the P84 neural adhesion molecule.</article-title><source>Journal of Biological Chemistry</source><volume>274</volume><fpage>559</fpage><lpage>562</lpage><pub-id pub-id-type="pmid">9872987</pub-id></citation></ref><ref id="pone.0003291-Timms1"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Timms</surname><given-names>JF</given-names></name><name><surname>Carlberg</surname><given-names>K</given-names></name><name><surname>Gu</surname><given-names>H</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Kamatkar</surname><given-names>S</given-names></name><etal/></person-group><year>1998</year><article-title>Identification of major binding proteins and substrates for the SH2-containing protein tyrosine phosphatase SHP-1 in macrophages.</article-title><source>Mol Cell Biol</source><volume>18</volume><fpage>3838</fpage><lpage>3850</lpage><pub-id pub-id-type="pmid">9632768</pub-id></citation></ref><ref id="pone.0003291-Saginario1"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saginario</surname><given-names>C</given-names></name><name><surname>Sterling</surname><given-names>H</given-names></name><name><surname>Beckers</surname><given-names>C</given-names></name><name><surname>Kobayashi</surname><given-names>R</given-names></name><name><surname>Solimena</surname><given-names>M</given-names></name><etal/></person-group><year>1998</year><article-title>MFR, a putative receptor mediating the fusion of macrophages.</article-title><source>Mol Cell Biol</source><volume>18</volume><fpage>6213</fpage><lpage>6223</lpage><pub-id pub-id-type="pmid">9774638</pub-id></citation></ref><ref id="pone.0003291-Patel1"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname><given-names>V</given-names></name><name><surname>Smith</surname><given-names>RE</given-names></name><name><surname>Serra</surname><given-names>A</given-names></name><name><surname>Brooke</surname><given-names>G</given-names></name><name><surname>Howard</surname><given-names>CJ</given-names></name><etal/></person-group><year>2002</year><article-title>MyD-1 (SIRPalpha) regulates T cell function in the absence of exogenous danger signals, via a TNFalpha-dependent pathway.</article-title><source>Eur J Immunol</source><volume>32</volume><fpage>1865</fpage><lpage>1872</lpage><pub-id pub-id-type="pmid">12115605</pub-id></citation></ref><ref id="pone.0003291-Barclay1"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barclay</surname><given-names>AN</given-names></name><name><surname>Brown</surname><given-names>MH</given-names></name></person-group><year>2006</year><article-title>The SIRP family of receptors and immune regulation.</article-title><source>Nat Rev Immunol</source><volume>6</volume><fpage>457</fpage><lpage>464</lpage><pub-id pub-id-type="pmid">16691243</pub-id></citation></ref><ref id="pone.0003291-Liu1"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Soto</surname><given-names>I</given-names></name><name><surname>Tong</surname><given-names>Q</given-names></name><name><surname>Chin</surname><given-names>A</given-names></name><name><surname>Buhring</surname><given-names>HJ</given-names></name><etal/></person-group><year>2005</year><article-title>SIRPbeta1 is expressed as a disulfide-linked homodimer in leukocytes and positively regulates neutrophil transepithelial migration.</article-title><source>J Biol Chem</source><volume>280</volume><fpage>36132</fpage><lpage>36140</lpage><pub-id pub-id-type="pmid">16081415</pub-id></citation></ref><ref id="pone.0003291-Fujioka1"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fujioka</surname><given-names>Y</given-names></name><name><surname>Matozaki</surname><given-names>T</given-names></name><name><surname>Noguchi</surname><given-names>T</given-names></name><name><surname>Iwamatsu</surname><given-names>A</given-names></name><name><surname>Yamao</surname><given-names>T</given-names></name><etal/></person-group><year>1996</year><article-title>A novel membrane glycoprotein, SHPS-1, that binds the SH2-domain-containing protein tyrosine phosphatase SHP-2 in response to mitogens and cell adhesion.</article-title><source>Mol Cell Biol</source><volume>16</volume><fpage>6887</fpage><lpage>6899</lpage><pub-id pub-id-type="pmid">8943344</pub-id></citation></ref><ref id="pone.0003291-Kharitonenkov1"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kharitonenkov</surname><given-names>A</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Sures</surname><given-names>I</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Schilling</surname><given-names>J</given-names></name><etal/></person-group><year>1997</year><article-title>A family of proteins that inhibit signalling through tyrosine kinase receptors.</article-title><source>Nature</source><volume>386</volume><fpage>181</fpage><lpage>186</lpage><pub-id pub-id-type="pmid">9062191</pub-id></citation></ref><ref id="pone.0003291-Yamao1"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yamao</surname><given-names>T</given-names></name><name><surname>Noguchi</surname><given-names>T</given-names></name><name><surname>Takeuchi</surname><given-names>O</given-names></name><name><surname>Nishiyama</surname><given-names>U</given-names></name><name><surname>Morita</surname><given-names>H</given-names></name><etal/></person-group><year>2002</year><article-title>Negative regulation of platelet clearance and of the macrophage phagocytic response by the transmembrane glycoprotein SHPS-1.</article-title><source>J Biol Chem</source><volume>277</volume><fpage>39833</fpage><lpage>39839</lpage><pub-id pub-id-type="pmid">12167615</pub-id></citation></ref><ref id="pone.0003291-Okazawa1"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Okazawa</surname><given-names>H</given-names></name><name><surname>Motegi</surname><given-names>S</given-names></name><name><surname>Ohyama</surname><given-names>N</given-names></name><name><surname>Ohnishi</surname><given-names>H</given-names></name><name><surname>Tomizawa</surname><given-names>T</given-names></name><etal/></person-group><year>2005</year><article-title>Negative regulation of phagocytosis in macrophages by the CD47-SHPS-1 system.</article-title><source>J Immunol</source><volume>174</volume><fpage>2004</fpage><lpage>2011</lpage><pub-id pub-id-type="pmid">15699129</pub-id></citation></ref><ref id="pone.0003291-Smith1"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>RE</given-names></name><name><surname>Patel</surname><given-names>V</given-names></name><name><surname>Seatter</surname><given-names>SD</given-names></name><name><surname>Deehan</surname><given-names>MR</given-names></name><name><surname>Brown</surname><given-names>MH</given-names></name><etal/></person-group><year>2003</year><article-title>A novel MyD-1 (SIRP-1alpha) signaling pathway that inhibits LPS-induced TNFalpha production by monocytes.</article-title><source>Blood</source><volume>102</volume><fpage>2532</fpage><lpage>2540</lpage><pub-id pub-id-type="pmid">12805067</pub-id></citation></ref><ref id="pone.0003291-Liu2"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Buhring</surname><given-names>HJ</given-names></name><name><surname>Zen</surname><given-names>K</given-names></name><name><surname>Burst</surname><given-names>SL</given-names></name><name><surname>Schnell</surname><given-names>FJ</given-names></name><etal/></person-group><year>2002</year><article-title>Signal regulatory protein (SIRPalpha), a cellular ligand for CD47, regulates neutrophil transmigration.</article-title><source>J Biol Chem</source><volume>277</volume><fpage>10028</fpage><lpage>10036</lpage><pub-id pub-id-type="pmid">11792697</pub-id></citation></ref><ref id="pone.0003291-deVries1"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>de Vries</surname><given-names>HE</given-names></name><name><surname>Hendriks</surname><given-names>JJ</given-names></name><name><surname>Honing</surname><given-names>H</given-names></name><name><surname>De Lavalette</surname><given-names>CR</given-names></name><name><surname>van der Pol</surname><given-names>SM</given-names></name><etal/></person-group><year>2002</year><article-title>Signal-regulatory protein alpha-CD47 interactions are required for the transmigration of monocytes across cerebral endothelium.</article-title><source>J Immunol</source><volume>168</volume><fpage>5832</fpage><lpage>5839</lpage><pub-id pub-id-type="pmid">12023387</pub-id></citation></ref><ref id="pone.0003291-Liu3"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>SQ</given-names></name><name><surname>Alkema</surname><given-names>PK</given-names></name><name><surname>Tieche</surname><given-names>C</given-names></name><name><surname>Tefft</surname><given-names>BJ</given-names></name><name><surname>Liu</surname><given-names>DZ</given-names></name><etal/></person-group><year>2005</year><article-title>Negative regulation of monocyte adhesion to arterial elastic laminae by signal regulatory protein alpha and Src homology 2 domain-containing protein-tyrosine phosphatase-1.</article-title><source>J Biol Chem</source><volume>280</volume><fpage>39294</fpage><lpage>39301</lpage><pub-id pub-id-type="pmid">16159885</pub-id></citation></ref><ref id="pone.0003291-Inagaki1"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Inagaki</surname><given-names>K</given-names></name><name><surname>Yamao</surname><given-names>T</given-names></name><name><surname>Noguchi</surname><given-names>T</given-names></name><name><surname>Matozaki</surname><given-names>T</given-names></name><name><surname>Fukunaga</surname><given-names>K</given-names></name><etal/></person-group><year>2000</year><article-title>SHPS-1 regulates integrin-mediated cytoskeletal reorganization and cell motility.</article-title><source>Embo J</source><volume>19</volume><fpage>6721</fpage><lpage>6731</lpage><pub-id pub-id-type="pmid">11118207</pub-id></citation></ref><ref id="pone.0003291-Wu1"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>CJ</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Ullrich</surname><given-names>A</given-names></name><name><surname>Greene</surname><given-names>MI</given-names></name><name><surname>O'Rourke</surname><given-names>DM</given-names></name></person-group><year>2000</year><article-title>Inhibition of EGFR-mediated phosphoinositide-3-OH kinase (PI3-K) signaling and glioblastoma phenotype by signal-regulatory proteins (SIRPs).</article-title><source>Oncogene</source><volume>19</volume><fpage>3999</fpage><lpage>4010</lpage><pub-id pub-id-type="pmid">10962556</pub-id></citation></ref><ref id="pone.0003291-Valcourt1"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Valcourt</surname><given-names>U</given-names></name><name><surname>Merle</surname><given-names>B</given-names></name><name><surname>Gineyts</surname><given-names>E</given-names></name><name><surname>Viguet-Carrin</surname><given-names>S</given-names></name><name><surname>Delmas</surname><given-names>PD</given-names></name><etal/></person-group><year>2007</year><article-title>Non-enzymatic glycation of bone collagen modifies osteoclastic activity and differentiation.</article-title><source>J Biol Chem</source><volume>282</volume><fpage>5691</fpage><lpage>5703</lpage><pub-id pub-id-type="pmid">17142454</pub-id></citation></ref><ref id="pone.0003291-Zen1"><label>27</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zen</surname><given-names>K</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Cairo</surname><given-names>D</given-names></name><name><surname>Parkos</surname><given-names>CA</given-names></name></person-group><year>2002</year><article-title>CD11b/CD18-dependent interactions of neutrophils with intestinal epithelium are mediated by fucosylated proteoglycans.</article-title><source>J Immunol</source><volume>169</volume><fpage>5270</fpage><lpage>5278</lpage><pub-id pub-id-type="pmid">12391246</pub-id></citation></ref><ref id="pone.0003291-Ades1"><label>28</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ades</surname><given-names>EW</given-names></name><name><surname>Candal</surname><given-names>FJ</given-names></name><name><surname>Swerlick</surname><given-names>RA</given-names></name><name><surname>George</surname><given-names>VG</given-names></name><name><surname>Summers</surname><given-names>S</given-names></name><etal/></person-group><year>1992</year><article-title>HMEC-1: establishment of an immortalized human microvascular endothelial cell line.</article-title><source>J Invest Dermatol</source><volume>99</volume><fpage>683</fpage><lpage>690</lpage><pub-id pub-id-type="pmid">1361507</pub-id></citation></ref><ref id="pone.0003291-Zen2"><label>29</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zen</surname><given-names>K</given-names></name><name><surname>Cui</surname><given-names>LB</given-names></name><name><surname>Zhang</surname><given-names>CY</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name></person-group><year>2007</year><article-title>Critical Role of Mac-1 Sialyl Lewis X Moieties in Regulating Neutrophil Degranulation and Transmigration.</article-title><source>J Mol Biol</source></citation></ref><ref id="pone.0003291-Ryu1"><label>30</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ryu</surname><given-names>JW</given-names></name><name><surname>Hong</surname><given-names>KH</given-names></name><name><surname>Maeng</surname><given-names>JH</given-names></name><name><surname>Kim</surname><given-names>JB</given-names></name><name><surname>Ko</surname><given-names>J</given-names></name><etal/></person-group><year>2004</year><article-title>Overexpression of uncoupling protein 2 in THP1 monocytes inhibits beta2 integrin-mediated firm adhesion and transendothelial migration.</article-title><source>Arterioscler Thromb Vasc Biol</source><volume>24</volume><fpage>864</fpage><lpage>870</lpage><pub-id pub-id-type="pmid">15016641</pub-id></citation></ref><ref id="pone.0003291-Luscinskas1"><label>31</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Luscinskas</surname><given-names>FW</given-names></name><name><surname>Ding</surname><given-names>H</given-names></name><name><surname>Tan</surname><given-names>P</given-names></name><name><surname>Cumming</surname><given-names>D</given-names></name><name><surname>Tedder</surname><given-names>TF</given-names></name><etal/></person-group><year>1996</year><article-title>L- and P-selectins, but not CD49d (VLA-4) integrins, mediate monocyte initial attachment to TNF-alpha-activated vascular endothelium under flow in vitro.</article-title><source>J Immunol</source><volume>157</volume><fpage>326</fpage><lpage>335</lpage><pub-id pub-id-type="pmid">8683134</pub-id></citation></ref><ref id="pone.0003291-Zhang1"><label>32</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Issekutz</surname><given-names>AC</given-names></name></person-group><year>2002</year><article-title>Down-modulation of monocyte transendothelial migration and endothelial adhesion molecule expression by fibroblast growth factor: reversal by the anti-angiogenic agent SU6668.</article-title><source>Am J Pathol</source><volume>160</volume><fpage>2219</fpage><lpage>2230</lpage><pub-id pub-id-type="pmid">12057924</pub-id></citation></ref><ref id="pone.0003291-Sharlow1"><label>33</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sharlow</surname><given-names>ER</given-names></name><name><surname>Paine</surname><given-names>CS</given-names></name><name><surname>Babiarz</surname><given-names>L</given-names></name><name><surname>Eisinger</surname><given-names>M</given-names></name><name><surname>Shapiro</surname><given-names>S</given-names></name><etal/></person-group><year>2000</year><article-title>The protease-activated receptor-2 upregulates keratinocyte phagocytosis.</article-title><source>J Cell Sci</source><volume>113 (Pt 17)</volume><fpage>3093</fpage><lpage>3101</lpage><pub-id pub-id-type="pmid">10934047</pub-id></citation></ref><ref id="pone.0003291-Miyata1"><label>34</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Miyata</surname><given-names>T</given-names></name><name><surname>Inagi</surname><given-names>R</given-names></name><name><surname>Iida</surname><given-names>Y</given-names></name><name><surname>Sato</surname><given-names>M</given-names></name><name><surname>Yamada</surname><given-names>N</given-names></name><etal/></person-group><year>1994</year><article-title>Involvement of beta 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis. Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-alpha and interleukin-1.</article-title><source>J Clin Invest</source><volume>93</volume><fpage>521</fpage><lpage>528</lpage><pub-id pub-id-type="pmid">8113390</pub-id></citation></ref><ref id="pone.0003291-Peppa1"><label>35</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Peppa</surname><given-names>M</given-names></name><name><surname>Brem</surname><given-names>H</given-names></name><name><surname>Ehrlich</surname><given-names>P</given-names></name><name><surname>Zhang</surname><given-names>JG</given-names></name><name><surname>Cai</surname><given-names>W</given-names></name><etal/></person-group><year>2003</year><article-title>Adverse effects of dietary glycotoxins on wound healing in genetically diabetic mice.</article-title><source>Diabetes</source><volume>52</volume><fpage>2805</fpage><lpage>2813</lpage><pub-id pub-id-type="pmid">14578300</pub-id></citation></ref><ref id="pone.0003291-Schober1"><label>36</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schober</surname><given-names>JM</given-names></name><name><surname>Chen</surname><given-names>N</given-names></name><name><surname>Grzeszkiewicz</surname><given-names>TM</given-names></name><name><surname>Jovanovic</surname><given-names>I</given-names></name><name><surname>Emeson</surname><given-names>EE</given-names></name><etal/></person-group><year>2002</year><article-title>Identification of integrin alpha(M)beta(2) as an adhesion receptor on peripheral blood monocytes for Cyr61 (CCN1) and connective tissue growth factor (CCN2): immediate-early gene products expressed in atherosclerotic lesions.</article-title><source>Blood</source><volume>99</volume><fpage>4457</fpage><lpage>4465</lpage><pub-id pub-id-type="pmid">12036876</pub-id></citation></ref><ref id="pone.0003291-Simon1"><label>37</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Simon</surname><given-names>DI</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Xu</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>CQ</given-names></name><name><surname>Dong</surname><given-names>J</given-names></name><etal/></person-group><year>2000</year><article-title>Platelet glycoprotein ibalpha is a counterreceptor for the leukocyte integrin Mac-1 (CD11b/CD18).</article-title><source>J Exp Med</source><volume>192</volume><fpage>193</fpage><lpage>204</lpage><pub-id pub-id-type="pmid">10899906</pub-id></citation></ref><ref id="pone.0003291-Sotiriou1"><label>38</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sotiriou</surname><given-names>SN</given-names></name><name><surname>Orlova</surname><given-names>VV</given-names></name><name><surname>Al-Fakhri</surname><given-names>N</given-names></name><name><surname>Ihanus</surname><given-names>E</given-names></name><name><surname>Economopoulou</surname><given-names>M</given-names></name><etal/></person-group><year>2006</year><article-title>Lipoprotein(a) in atherosclerotic plaques recruits inflammatory cells through interaction with Mac-1 integrin.</article-title><source>Faseb J</source><volume>20</volume><fpage>559</fpage><lpage>561</lpage><pub-id pub-id-type="pmid">16403785</pub-id></citation></ref><ref id="pone.0003291-Mateo1"><label>39</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mateo</surname><given-names>V</given-names></name><name><surname>Brown</surname><given-names>EJ</given-names></name><name><surname>Biron</surname><given-names>G</given-names></name><name><surname>Rubio</surname><given-names>M</given-names></name><name><surname>Fischer</surname><given-names>A</given-names></name><etal/></person-group><year>2002</year><article-title>Mechanisms of CD47-induced caspase-independent cell death in normal and leukemic cells: link between phosphatidylserine exposure and cytoskeleton organization.</article-title><source>Blood</source><volume>100</volume><fpage>2882</fpage><lpage>2890</lpage><pub-id pub-id-type="pmid">12351399</pub-id></citation></ref><ref id="pone.0003291-Gafa1"><label>40</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gafa</surname><given-names>V</given-names></name><name><surname>Manches</surname><given-names>O</given-names></name><name><surname>Pastor</surname><given-names>A</given-names></name><name><surname>Drouet</surname><given-names>E</given-names></name><name><surname>Ambroise-Thomas</surname><given-names>P</given-names></name><etal/></person-group><year>2005</year><article-title>Human cytomegalovirus downregulates complement receptors (CR3, CR4) and decreases phagocytosis by macrophages.</article-title><source>J Med Virol</source><volume>76</volume><fpage>361</fpage><lpage>366</lpage><pub-id pub-id-type="pmid">15902695</pub-id></citation></ref><ref id="pone.0003291-Shi1"><label>41</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Sulaiman</surname><given-names>K</given-names></name><name><surname>Feinberg</surname><given-names>MW</given-names></name><etal/></person-group><year>2004</year><article-title>Integrin engagement regulates monocyte differentiation through the forkhead transcription factor Foxp1.</article-title><source>J Clin Invest</source><volume>114</volume><fpage>408</fpage><lpage>418</lpage><pub-id pub-id-type="pmid">15286807</pub-id></citation></ref><ref id="pone.0003291-Capo1"><label>42</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Capo</surname><given-names>C</given-names></name><name><surname>Moynault</surname><given-names>A</given-names></name><name><surname>Collette</surname><given-names>Y</given-names></name><name><surname>Olive</surname><given-names>D</given-names></name><name><surname>Brown</surname><given-names>EJ</given-names></name><etal/></person-group><year>2003</year><article-title>Coxiella burnetii avoids macrophage phagocytosis by interfering with spatial distribution of complement receptor 3.</article-title><source>J Immunol</source><volume>170</volume><fpage>4217</fpage><lpage>4225</lpage><pub-id pub-id-type="pmid">12682255</pub-id></citation></ref><ref id="pone.0003291-Kong1"><label>43</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kong</surname><given-names>XN</given-names></name><name><surname>Yan</surname><given-names>HX</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Dong</surname><given-names>LW</given-names></name><name><surname>Yang</surname><given-names>W</given-names></name><etal/></person-group><year>2007</year><article-title>LPS-induced down-regulation of signal regulatory protein {alpha} contributes to innate immune activation in macrophages.</article-title><source>J Exp Med</source><volume>204</volume><fpage>2719</fpage><lpage>2731</lpage><pub-id pub-id-type="pmid">17954568</pub-id></citation></ref><ref id="pone.0003291-Shahabuddin1"><label>44</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shahabuddin</surname><given-names>S</given-names></name><name><surname>Ponath</surname><given-names>P</given-names></name><name><surname>Schleimer</surname><given-names>RP</given-names></name></person-group><year>2000</year><article-title>Migration of eosinophils across endothelial cell monolayers: interactions among IL-5, endothelial-activating cytokines, and C-C chemokines.</article-title><source>J Immunol</source><volume>164</volume><fpage>3847</fpage><lpage>3854</lpage><pub-id pub-id-type="pmid">10725746</pub-id></citation></ref><ref id="pone.0003291-Papayannopoulou1"><label>45</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Papayannopoulou</surname><given-names>T</given-names></name><name><surname>Priestley</surname><given-names>GV</given-names></name><name><surname>Bonig</surname><given-names>H</given-names></name><name><surname>Nakamoto</surname><given-names>B</given-names></name></person-group><year>2003</year><article-title>The role of G-protein signaling in hematopoietic stem/progenitor cell mobilization.</article-title><source>Blood</source><volume>101</volume><fpage>4739</fpage><lpage>4747</lpage><pub-id pub-id-type="pmid">12595315</pub-id></citation></ref><ref id="pone.0003291-Weber1"><label>46</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Weber</surname><given-names>KS</given-names></name><name><surname>Klickstein</surname><given-names>LB</given-names></name><name><surname>Weber</surname><given-names>C</given-names></name></person-group><year>1999</year><article-title>Specific activation of leukocyte beta2 integrins lymphocyte function-associated antigen-1 and Mac-1 by chemokines mediated by distinct pathways via the alpha subunit cytoplasmic domains.</article-title><source>Mol Biol Cell</source><volume>10</volume><fpage>861</fpage><lpage>873</lpage><pub-id pub-id-type="pmid">10198043</pub-id></citation></ref><ref id="pone.0003291-Aiello1"><label>47</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aiello</surname><given-names>RJ</given-names></name><name><surname>Bourassa</surname><given-names>PA</given-names></name><name><surname>Lindsey</surname><given-names>S</given-names></name><name><surname>Weng</surname><given-names>W</given-names></name><name><surname>Freeman</surname><given-names>A</given-names></name><etal/></person-group><year>2002</year><article-title>Leukotriene B4 receptor antagonism reduces monocytic foam cells in mice.</article-title><source>Arterioscler Thromb Vasc Biol</source><volume>22</volume><fpage>443</fpage><lpage>449</lpage><pub-id pub-id-type="pmid">11884288</pub-id></citation></ref><ref id="pone.0003291-vanRoyen1"><label>48</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>van Royen</surname><given-names>N</given-names></name><name><surname>Hoefer</surname><given-names>I</given-names></name><name><surname>Bottinger</surname><given-names>M</given-names></name><name><surname>Hua</surname><given-names>J</given-names></name><name><surname>Grundmann</surname><given-names>S</given-names></name><etal/></person-group><year>2003</year><article-title>Local monocyte chemoattractant protein-1 therapy increases collateral artery formation in apolipoprotein E-deficient mice but induces systemic monocytic CD11b expression, neointimal formation, and plaque progression.</article-title><source>Circ Res</source><volume>92</volume><fpage>218</fpage><lpage>225</lpage><pub-id pub-id-type="pmid">12574150</pub-id></citation></ref><ref id="pone.0003291-Brown1"><label>49</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>E</given-names></name></person-group><year>2001</year><article-title>Integrin-associated protein (CD47): an unusual activator of G protein signaling.</article-title><source>J Clin Invest</source><volume>107</volume><fpage>1499</fpage><lpage>1500</lpage><pub-id pub-id-type="pmid">11413154</pub-id></citation></ref></ref-list><fn-group><fn fn-type="conflict"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><fn fn-type="financial-disclosure"><p><bold>Funding: </bold>This work was supported in part by China Basic Science 973 program (CYZ, KZ).</p></fn></fn-group></back></article> 